Literature DB >> 12115311

Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal.

Kelly M McMasters1, Celia Chao, Sandra L Wong, Robert C G Martin, Michael J Edwards.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12115311     DOI： 10.1002/cncr.10641

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  9 in total

1.  Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ.

Authors:  Ahmed Yahia Al-Ameer; Sahar Al Nefaie; Badria Al Johani; Ihab Anwar; Taher Al Tweigeri; Asma Tulbah; Mohmmed Alshabanah; Osama Al Malik
Journal:  World J Clin Oncol       Date:  2016-04-10

2.  Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study.

Authors:  Gábor Cserni; Simonetta Bianchi; Vania Vezzosi; Riccardo Arisio; Rita Bori; Johannes L Peterse; Anna Sapino; Isabella Castellano; Maria Drijkoningen; Janina Kulka; Vincenzo Eusebi; Maria P Foschini; Jean-Pierre Bellocq; Cristi Marin; Sten Thorstenson; Isabel Amendoeira; Angelika Reiner-Concin; Thomas Decker; Manuela Lacerda; Paulo Figueiredo; Gábor Fejes
Journal:  Pathol Oncol Res       Date:  2007-03-27       Impact factor: 3.201

3.  Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer.

Authors:  Robert C G Martin; Anees Chagpar; Charles R Scoggins; Michael J Edwards; Lee Hagendoorn; Arnold J Stromberg; Kelly M McMasters
Journal:  Ann Surg       Date:  2005-06       Impact factor: 12.969

4.  Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay.

Authors:  T Osako; T Iwase; K Kimura; K Masumura; R Horii; F Akiyama
Journal:  Br J Cancer       Date:  2012-05-08       Impact factor: 7.640

5.  Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120).

Authors:  X Papanikolaou; A Rosenthal; M Dhodapkar; J Epstein; R Khan; F van Rhee; Y Jethava; S Waheed; M Zangari; A Hoering; J Crowley; D Alapat; F Davies; G Morgan; B Barlogie
Journal:  Blood Cancer J       Date:  2016-03-25       Impact factor: 11.037

Review 6.  Sentinel Lymph Node Biopsy in Breast Cancer.

Authors:  Vijaya V Mysorekar
Journal:  World J Oncol       Date:  2010-02-01

7.  Pure Ductal Carcinoma In Situ of the Breast: Analysis of 270 Consecutive Patients Treated in a 9-Year Period.

Authors:  Corrado Chiappa; Alice Bonetti; Giulio Jad Jaber; Valentina De Berardinis; Veronica Bianchi; Francesca Rovera
Journal:  Cancers (Basel)       Date:  2021-01-23       Impact factor: 6.639

8.  Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience.

Authors:  B Cutuli; C Lemanski; A Fourquet; B de Lafontan; S Giard; A Meunier; R Pioud-Martigny; F Campana; H Marsiglia; S Lancrenon; E Mery; F Penault-Llorca; E Fondrinier; C Tunon de Lara
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

9.  Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ.

Authors:  Tomo Osako; Takuji Iwase; Masaru Ushijima; Rie Horii; Yasuyoshi Fukami; Kiyomi Kimura; Masaaki Matsuura; Futoshi Akiyama
Journal:  Cancer Sci       Date:  2014-03-26       Impact factor: 6.716
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.